Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2009
09/16/2009EP2099759A1 Antibacterial quinoline derivatives
09/16/2009EP2099758A1 Antibacterial quinoline derivatives
09/16/2009EP2099757A2 Sulfoximines as kinase inhibitors
09/16/2009EP2099755A2 Acetylene derivatives as stearoyl coa desaturase inhibitors
09/16/2009EP2099753A2 Heteroarylacrylamides and their use as pharmaceuticals
09/16/2009EP2099752A1 Phenylamino-substituted piperidine compounds, their preparation and use as medicaments
09/16/2009EP2099501A1 2,6-diphenyl-4,8-diazoadamantan-1-one and derivatives thereof, process of manufacture and use for the formulation of solutions with sterilizing and disinfectant effect
09/16/2009EP2099303A1 Therapeutic tetrahydroisoquinoline-based compositions for cancer therapy
09/16/2009EP1581488B1 Inhibitors of tace
09/16/2009EP1578737B1 Substituted heterocyclic compounds
09/16/2009EP1564210B1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
09/16/2009EP1517919B9 Marked peptides having affinity for a phospholipid and uses
09/16/2009EP1487807B1 Cyano-pyrrolidines as DPP-IV inhibitors
09/16/2009EP1419149B1 Benzo[g]quinoline derivatives for treating glaucoma and myopia
09/16/2009EP1411046B1 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
09/16/2009CN101535296A 2-benzimidazolyl-6-morpholino-4-phenylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
09/16/2009CN101535295A Quinoline derivatives for modulating DNA methylation
09/16/2009CN101535294A Macrocyclic inhibitors of hepatitis C virus
09/16/2009CN101535293A Heterocyclic derivatives as CETP inhibitors
09/16/2009CN101535292A Substituted 2-imidazoles as modulators of the trace amine associated receptors
09/16/2009CN101535291A 5-substituted quinazolinone derivatives used as antineoplastic drug
09/16/2009CN101532992A Method for detecting purithiamine in blood by efficient liquid chromatography
09/16/2009CN101531654A Preparation method for Rupatadine
09/16/2009CN101531653A Salts of 3-(4-amino-1-oxo-1,3-dihydro-iso-indol-2-yl)piperdine-2,6-dione and derivatives thereof, polymorph of the salts, preparation and application thereof
09/16/2009CN100540548C Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
09/16/2009CN100540547C Inhibitors of histone deacetylase
09/16/2009CN100540538C Large conductance calcium-activated k channel opener
09/16/2009CN100540537C Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
09/15/2009US7589207 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide
09/15/2009US7589200 5-Fluoro-4N-phenyl-4-pyrimidineamine compounds
09/15/2009US7589199 Substituted piperazines
09/15/2009US7589116 Biaryl substituted pyrazoles as sodium channel blockers
09/15/2009US7589112 Methylene urea derivatives
09/15/2009US7589108 3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-indole hydrochloride for treatment of central nervous system disorders associated with 5-HT serotonin receptors
09/15/2009US7589098 Controlling cell proliferation; side effect reduction ; anticancer agenst
09/15/2009US7589096 3-(3-biphenylyl)-5-[3-oxospiro[6-azaisobenzofuran-1(3H),4'-piperidin]-1'-yl]-1H-pyrazole; neuropeptide Y receptor antagonists; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization
09/15/2009US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds
09/15/2009US7589087 [5-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-pyridin-2-yl]-methyl-[3-(1-methyl-piperidin-4-yl)-propyl]-amine; for diseases related to H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus
09/15/2009US7589085 Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity
09/15/2009CA2522323C 3-azabicyclo[3.2.1]octane derivatives as opioid receptor ligands
09/15/2009CA2409819C Triazole derivatives
09/15/2009CA2407754C Prodrugs of hiv replication inhibiting pyrimidines
09/15/2009CA2406562C Hiv replication inhibiting pyrimidines and triazines
09/15/2009CA2389163C Process for the production of antiulceratives
09/15/2009CA2364665C Phenyl- and pyridinyl derivatives
09/15/2009CA2362363C Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
09/15/2009CA2323111C New substituted indolinones, the preparation thereof and their use as pharmaceutical compositions
09/15/2009CA2274204C Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole]
09/11/2009WO2009111447A2 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers
09/11/2009WO2009111442A1 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
09/11/2009WO2009110844A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof
09/11/2009WO2009110520A1 Heterocyclic compound
09/11/2009WO2009110510A1 Alkylaminopyridine derivative
09/11/2009WO2009110468A1 Potassium channel opener
09/11/2009WO2009110000A1 Novel napthalimide-benzimidazole hybrids as potential antitumour agents and process for the preparation thereof
09/11/2009WO2009109991A2 Novel hydrazide containing tyrosine kinase inhibitors
09/11/2009WO2009109867A2 Crystal form of phenylamino pyrimidine derivatives
09/11/2009WO2009109866A2 Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-n-[4-methyl-3- (4-pyridin-3-yl-pyrimidin-2ylamino)-phenyl]-benzamide
09/11/2009WO2009109743A1 Azetidine derivatives
09/11/2009WO2009109710A1 Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof
09/11/2009WO2009109654A2 Novel 1-benzyl-3-hydroxymethyilindazole derivatives and use thereof in the treatment of diseases based on the expression mcp-1 and cx3cr1
09/11/2009WO2009109616A2 Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
09/11/2009WO2009109608A1 Novel compounds
09/11/2009WO2009109502A1 2-aminoquinolines
09/11/2009WO2009109491A1 2-aminoquinoline derivatives
09/11/2009WO2009109477A1 2-aminoquinolines
09/11/2009WO2009109364A1 Substituted sulfonamide derivatives
09/11/2009WO2009109230A1 2-aryl and 2 -heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives for the treatment of arthritis, cancer and related pain
09/11/2009WO2009080367A3 Specific inhibitors of pteridine reductase with antiparasitic action
09/11/2009CA2717750A1 Azetidine derivatives
09/11/2009CA2717604A1 Substituted sulfonamide derivatives
09/11/2009CA2717478A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof
09/11/2009CA2717171A1 Amino-quinoxaline and amino-quinoline compounds for use as adenosine a2a receptor antagonists
09/11/2009CA2717138A1 Heterocyclic compound
09/11/2009CA2716767A1 Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide
09/11/2009CA2716741A1 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers
09/11/2009CA2716413A1 Crystal form of phenylamino pyrimidine derivatives
09/11/2009CA2716136A1 Hexahydrocyclopentyl[f]indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
09/11/2009CA2716122A1 2-aminoquinolines
09/11/2009CA2715842A1 2-aminoquinoline derivatives
09/11/2009CA2715796A1 2-aryl and 2 -heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives for the treatment of arthritis, cancer and related pain
09/11/2009CA2715065A1 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression mcp-1 and cx3cr1
09/11/2009CA2714617A1 Alkylaminopyridine derivative
09/11/2009CA2714436A1 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
09/11/2009CA2712921A1 Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof
09/11/2009CA2711247A1 2-aminoquinolines
09/10/2009US20090227797 Modulators of atp-binding cassette transporters
09/10/2009US20090227789 Ethylenediamine derivatives
09/10/2009US20090227635 Therapeutic compounds
09/10/2009US20090227629 Compounds having activity at the glycine transporter glyt1 and uses thereof
09/10/2009US20090227614 Modulators of Muscarinic Receptors
09/10/2009US20090227611 Crystal form of phenylamino pyrimidine derivatives
09/10/2009US20090227602 Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
09/10/2009US20090227601 Bradykinin 1 Receptor Antagonists
09/10/2009US20090227596 Heteroaryl nitrile derivatives
09/10/2009US20090227593 Cyclobutyl amine derivatives
09/10/2009US20090227592 Compounds effecting glucokinase
09/10/2009US20090227591 Cyclopentene compounds
09/10/2009US20090227590 Quaternary ammonium salts as m3 antagonists
09/10/2009US20090227588 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors